Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Apotheekbereiding in de geneesmiddelenvoorziening hoofdstuk lezen eerste hoofdstuk lezen

2009 | OriginalPaper | Hoofdstuk

30 Neus

Auteurs : Annick Ludwig, Suzy Dreijer

Gepubliceerd in: Recepteerkunde

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

In dit hoofdstuk bespreken wij de preparaten voor de neus, zowel voor lokaal gebruik als voor systemisch effect. De nadruk ligt op toedieningsvormen die in de apotheek worden bereid.
vorige hoofdstuk 29 Mond en keel
volgende hoofdstuk 31 Oor
Literatuur
1.
Martin E, Schipper NGM, Verhoef JC, et al. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Del Rev 1998;29:13–38.
2.
Merkus FWHM. Intranasale toediening van geneesmiddelen. Pharm Weekbl 2001;136:503–506.
3.
Costantino HR, Illum L, Brandt G, etal. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 2007;337:1–24.CrossRefPubMed
4.
Gillis JC, Benfield P, Goa KL. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute pain management. Drugs 1995;50(1):158–75.
5.
Essink AWG, Rutten WJ. Bereiding van apomorfine neusspray. Pharm Weekbl 1991;126:1113–4.
6.
Hochhaus G, Sahasranaman S, Derendorf H, et al. Intranasal glucocorticoid delivery: competition between local and systemic effects. S.T.P. Pharma Sciences 2002;12:23–31.
7.
Deutscher Arzneimittel-Codex, Neues Rezeptur-Formularium. Frankfurt a.M.: Govi-Verlag Pharmazeutischer Verlag. Stuttgart: Deutscher Apotheker-Verlag, 2006:nr.4.11: Natriumchlorid-Natriumwasserstofcarbonat-Salzmischung.
8.
Behl CR, Pimplaskar HK, Sileno AP, et al. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Del Rev 1998;29:89–116.
9.
Harris AS, Nilsson IM, Wagner ZG, et al. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. J Pharm Sci 1986;75:1085–1088.PubMed
10.
Al-Ghananeem AM, Sandefer EP, Doll WJ, et al. Gamma scintigraphy for testing bioequivalence: a case study on two cromolyn sodium nasal spray preparations. Int J Pharm 2008;357:70–76.CrossRefPubMed
11.
Newman SP, Pitcairn GR, Dalby RN. Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit Rev Ther Drug Carrier Syst 2004;21:21–66.CrossRefPubMed
12.
Kublik H, Vidgren MT. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Del Rev 1998;29:157–177.CrossRef
13.
Segers P, Speekenbrink RGH, Ubbink DT, et al. Preventie van ziekenhuisinfecties na hartoperaties door decontaminatie van de naso- en orofarynx met chloorhexidine; prospectief, gerandomiseerd onderzoek. Ned Tijdschr Geneeskd 2008;152:760–7.PubMed
14.
European Pharmacopoeia, 6de ed. Straatsburg: Council of Europe, 2009.
15.
Ugwoke MI, Agu RU, Verbeke N, et al. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Del Rev 2005;57:1640–1665.CrossRef
16.
Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001;53:3–22.CrossRef
17.
Bernards JA, Bouman LN, Boddeke HWGM. Medische Fysiologie. Houten: Bohn Stafleu van Loghum, 2008.
18.
Mygind N, Dahl R. Anatomy, physiology and function of the nasal cavities in health and disease. Adv Drug Del Rev 1998;29:3–12.CrossRef
19.
Schipper NGM, Verhoef JC, Merkus WHM. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm Res 1991;8:807–14.CrossRefPubMed
20.
Duchateau GSMJE, Graamans K, Zuidema J, et al. Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers. Laryngoscope 1985;95:854–9.CrossRefPubMed
21.
Mallants R, Jorissen M, Augustijns P. Effect of preservatives on ciliary beat frequency in human nasal epithelial cell culture: single versus multiple exposure. Int J Pharm 2007;338:64–69.CrossRefPubMed
22.
van de Donk HJM. Nasal medication and ciliary movement. Amsterdam: Rodopi, 1982.
23.
24.
Knoester PD, Jonker DM, van der Hoeven RTM, et al. Midazolam intranasaal toegepast. Eventueel als noodmedicatie. Pharm Weekbl 2002;137:112–117.
25.
Tenk H, Jonker DM, van der Hoeven RTM, et al. De spiegels zijn goed; nu nog de waarde in de praktijk. Midazolam neusspray bij patiënten met epilepsie. Pharm Weekbl 2003;138:99–103.
26.
Ugwoke MI, Agu RU, Jorissen M, et al. Nasal toxicological investigations of Carbopol 971P formulation of apomorfine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur J Pharm Sci 2000;9:387–396.PubMed
27.
Ugwoke MI, Agu RU, Jorissen M, et al. Toxicological investigations of the effects of carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int J Pharm 2000;205: 43–51.CrossRefPubMed
28.
Soane RJ, Frier M, Perkins AC, et al. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm 1999;178:55–65.CrossRefPubMed
29.
Li L, Mathias NR, Heran CL, et al. Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers. J Pharm Sci 2006;95:326–335.PubMed
30.
Lee VH, Yamamoto A, Kompella UB. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit Rev Ther Drug Carrier Syst 1991;8:91–192.PubMed
31.
Zaki NM, Awad GA, Mortada ND, et al. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 2007;32:296–307.PubMed
32.
Gudmundsdottir H, Sigurjonsdottir JF, Masson M, et al. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie 2001;56:963–966.PubMed
33.
Loftsson T, Gudmundsdottir H, Sigurjonsdottir JF, et al. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm 2001;212:29–40.CrossRefPubMed
34.
Marttin E, Verhoef JC, Romeijn SG, et al. Acute histopathological effects of benzalkonium chloride and absorption enhancers on rat nasal epithelium in vivo. Int J Pharm 1996;141:151–160.CrossRef
35.
Merkus FWHM, Verhoef JC, Marttin E, et al. Cyclodextrins in nasal delivery. Adv Drug Del Rev 1999;36:41–57.CrossRef
36.
Asai K, Morishita M, Katsuta H, et al. The effects of water-soluble cyclodextrines on the histological integrity of the rat nasal mucosa. Int J Pharm 2002;246:25–35.CrossRefPubMed
37.
Haffejee N, Du Plessis J, Müller DG, et al. Intranasal toxicity of selected absorption enhancers. Pharmazie 2001;5:882–888.
38.
Zaki NM, Mortada ND, Awad GAS, et al. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part II: Safety of various absorption enhancers and pharmacokinetic evaluation. Int J Pharm 2006;327:97–103.CrossRefPubMed
39.
van ‘t Veen AJ, van Joost T. Bron en praktische betekenis van allergie voor thiomersal, een organische kwikverbinding. Ned Tijdschr Geneeskd 1996;140:297–300.
40.
Jian L, Li Wan Po A. Ciliotoxicity of methyl- and propyl-p-hydroxybenzoates: a dose response and surface response study. J Pharm Pharmacol 1993;45:925–27.
41.
Hodges NA, Denyer SP, Hanlon GW, et al. Preservative efficacy tests in formulated nasal products: reproducibility and factors affecting preservative activity. J Pharm Pharmacol 1996;48:1237–42.CrossRefPubMed
42.
Boer Y, van Kooij Y. Oogdruppels en neussprays zonder conserveermiddel in opmars. Pharm Weekbl 1997;132:1914–5.
43.
Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J. Pharm Pharmacol 1985;37:294–297.PubMed
44.
Feenstra L. De lichaamshouding bij neusdruppelen voor behandeling van poliepen. Ned Tijdschr Geneeskd 1986;130:41–5.
45.
Pennington AK, Ratcliffe JH, Wilson CG, rt al. The influence of solution viscosity on nasal spray deposition and clearance. Int J Pharm 1988;43:221–4.CrossRef
Metagegevens
Titel
30 Neus
Auteurs
Annick Ludwig
Suzy Dreijer
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
Boek
Recepteerkunde

Print ISBN: 978-90-313-5316-3

Elektronisch ISBN: 978-90-313-8032-9

Copyright: 2009

DOI
https://doi.org/10.1007/978-90-313-8032-9_30